Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application USA - English - USA - English - PR Newswire
prnewswire.comSubmitted by prnewswire4384 in business
/PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax® personalized immune therapies for solid tumor...